Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
AEHR TEST SYSTEMS chief technology officer Donald P. Richmond II reported a routine tax-related share withholding. On 01/14/2026, 343 shares of common stock were withheld at a price of $25.97 per share to cover tax obligations triggered by the vesting of restricted stock units, and this was not an open-market sale. After this transaction, he beneficially owned 213,334 shares, which include shares subject to unvested restricted stock units, all held in direct ownership form.
AEHR Test Systems President and CEO Erickson Gayn reported a tax-related share withholding rather than an open-market sale. On January 14, 2026, 2,680 shares of common stock were withheld at $25.97 per share to cover tax obligations triggered by the vesting of restricted stock units and restricted shares, and the filing states this does not represent a sale by the reporting person. Following this transaction, Gayn directly beneficially owned 252,119 shares of common stock and indirectly beneficially owned 291,628 shares through a trust, with the indirect holdings reported as "By Trust."
Aehr Test Systems VP of Engineering filed an amended Form 4 to correct previously reported figures related to a tax withholding transaction on common stock dated 01/11/2026. The amendment clarifies that 486 shares were withheld to satisfy tax obligations at a price of $26.32 per share, rather than the 576 shares originally reported. It also updates the officer’s direct beneficial ownership after the transaction from the previously stated 213,587 shares to the correct total of 213,677 common shares.
AEHR TEST SYSTEMS President and CEO Erickson Gayn reported tax-related share withholding, not an open-market sale. On January 11, 2026, 3,531 shares of AEHR common stock were withheld at $26.32 per share to cover tax obligations triggered by the vesting of restricted stock units and restricted shares, as explained in the footnote.
After this transaction, Gayn beneficially owned 254,799 shares of common stock directly and 291,628 shares indirectly through a trust. The indirect amount includes shares subject to unvested restricted stock units and unvested restricted shares.
AEHR TEST SYSTEMS executive Vernon Rogers reported a routine tax-related share withholding tied to restricted stock units. On 01/11/2026, 576 shares of common stock were withheld at $26.32 per share to cover tax obligations when his restricted stock units vested, and this was not an open-market sale by Rogers. Following this transaction, he beneficially owned 177,830 shares of AEHR common stock, which the disclosure notes includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS CTO Donald P. Richmond II reported a routine share withholding transaction related to equity compensation. On 01/11/2026, 576 shares of common stock were withheld at $26.32 per share to cover tax obligations that arose when restricted stock units vested. The filing states this does not represent a sale by the reporting person, but an administrative tax withholding.
After this transaction, Richmond beneficially owned 213,587 shares of AEHR Test Systems common stock, and this amount includes shares subject to unvested restricted stock units. The filing confirms that these holdings are reported as directly owned.
AEHR Test Systems chief financial officer Siu Chris reported an automatic share withholding related to equity compensation. On January 11, 2026, 799 shares of common stock were withheld at $26.32 per share to cover tax obligations when restricted stock units vested, which the filing clarifies does not represent a sale by the executive. After this transaction, the CFO beneficially owned 72,626 shares of AEHR common stock directly, and an additional 5,211 shares held indirectly by a trust. The reported direct holdings include shares underlying unvested restricted stock units.
AEHR TEST SYSTEMS VP Contactor Business Unit Alistair N. Sporck filed a Form 4 reporting a tax-related share withholding. On January 11, 2026, 239 shares of common stock were withheld at $26.32 per share to satisfy tax obligations upon the vesting of restricted stock units, and this is explicitly stated as not a sale by the reporting person.
After this withholding, Sporck beneficially owns 28,692 shares of common stock directly, which include shares subject to unvested restricted stock units, and an additional 5,214 shares indirectly held by a trust.
Aehr Test Systems Chief Operating Officer Engineer Adil reported an automatic share withholding related to restricted stock units, not an open-market sale. On January 11, 2026, 444 shares of common stock were withheld at $26.32 per share to cover tax obligations when restricted stock units vested. After this entry, Adil beneficially owned 45,839 shares of Aehr Test Systems common stock, which includes shares subject to unvested restricted stock units.
Aehr Test Systems reported weaker results for the quarter ended November 28, 2025. Revenue fell to $9.9 million from $13.5 million, a 27% decline, mainly from lower contactor shipments tied to softness in electric vehicle demand. Six‑month revenue dropped 22% to $20.9 million.
Gross margin compressed to 25.7% from 40.1% as lower production, mix shifts, higher assembly and warranty costs, freight, and tariffs weighed on profitability. Aehr posted a quarterly net loss of $3.2 million, or $0.11 per share, versus a $1.0 million loss a year earlier; six‑month net loss widened to $5.3 million or $0.18 per share.
The company continues to invest in development, with research and development expenses up 31% in the quarter, and is seeing growth in package‑level burn‑in systems and AI‑related applications. Aehr strengthened liquidity by selling 384,380 shares via its ATM program for roughly $10 million of gross proceeds, ending the period with $31.0 million in cash, cash equivalents, and restricted cash and no off‑balance‑sheet debt arrangements disclosed.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
